ES8800148A1 - Un procedimiento para la preparacion de un derivado de 2-pirrolidona - Google Patents

Un procedimiento para la preparacion de un derivado de 2-pirrolidona

Info

Publication number
ES8800148A1
ES8800148A1 ES554775A ES554775A ES8800148A1 ES 8800148 A1 ES8800148 A1 ES 8800148A1 ES 554775 A ES554775 A ES 554775A ES 554775 A ES554775 A ES 554775A ES 8800148 A1 ES8800148 A1 ES 8800148A1
Authority
ES
Spain
Prior art keywords
preparing
pharmaceutical composition
pyrrolidone derivatives
alkylene
pyrrolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554775A
Other languages
English (en)
Other versions
ES554775A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8800148A1 publication Critical patent/ES8800148A1/es
Publication of ES554775A0 publication Critical patent/ES554775A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN DERIVADO DE 2-PIRROLIDONA. CONSISTE EN HACER REACCIONAR AL 3,5-DI-T-BUTIL-4-HIDROXIBENZALDEHIDO CON UN COMPUESTO DE FORMULA (II), EN DIMETILFORMAMIDA, ENTRE 0G Y 150GC Y EN PRESENCIA DE TRIETILAMINA, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: R, H, ALQUILO INFERIOR, ALCOXI INFERIOR O -(CH2)NX; R ELEVADO A 1 Y R ELEVADO A 2, H O ALQUILO INFERIOR; X, FENILO O -NR''R ELEVADO A 2, W, =P(C6H5)3 O -P+(C6H5); Y N, DE 1 A 2. SE UTILIZAN COMO ANTIINFLAMATORIOS Y ANALGESICOS. *FORMULA*
ES554775A 1985-05-09 1986-05-08 Un procedimiento para la preparacion de un derivado de 2-pirrolidona Expired ES8800148A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60096799A JPH066571B2 (ja) 1985-05-09 1985-05-09 ２−ピロリドン誘導体

Publications (2)

Publication Number Publication Date
ES8800148A1 true ES8800148A1 (es) 1987-11-01
ES554775A0 ES554775A0 (es) 1987-11-01

Family

ID=14174668

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554775A Expired ES8800148A1 (es) 1985-05-09 1986-05-08 Un procedimiento para la preparacion de un derivado de 2-pirrolidona

Country Status (19)

Country Link
US (1) US4833160A (es)
EP (1) EP0204964B1 (es)
JP (1) JPH066571B2 (es)
KR (1) KR910004789B1 (es)
CN (1) CN1014058B (es)
AT (1) ATE66673T1 (es)
AU (1) AU581078B2 (es)
CA (1) CA1264762A (es)
DE (1) DE3681076D1 (es)
DK (1) DK213286A (es)
ES (1) ES8800148A1 (es)
FI (1) FI84172C (es)
HU (2) HU199117B (es)
MX (1) MX162717A (es)
NO (1) NO861820L (es)
NZ (1) NZ216092A (es)
PH (2) PH23189A (es)
PT (1) PT82540B (es)
ZA (1) ZA863352B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
WO1988007035A1 (en) * 1987-03-11 1988-09-22 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene derivatives
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
JP3108097B2 (ja) * 1991-01-21 2000-11-13 塩野義製薬株式会社 ３−ベンジリデン−１−カルバモイル−２−ピロリドン類縁体
WO1992017447A1 (en) * 1991-04-05 1992-10-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Phenoxybenzene derivative
EP0595546B1 (en) * 1992-10-28 1996-03-20 Shionogi & Co., Ltd. Benzylidene derivatives
US5358964A (en) * 1993-07-26 1994-10-25 Warner-Lambert Company Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation
GB9704499D0 (en) 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
CN103342672B (zh) * 2013-07-02 2015-12-23 扬州大学 取代吡咯烷-2-酮的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714153A (en) * 1970-06-22 1973-01-30 Roussel Uclaf Novel cyclopropanecarboxylic acids
DE2329308A1 (de) * 1972-03-03 1975-01-02 Gruenenthal Chemie Neue lactame
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
US4138495A (en) * 1978-05-19 1979-02-06 Stauffer Chemical Company N-Substituted pyrrolidones and their use as miticides
US4440784A (en) * 1981-02-05 1984-04-03 Kanegafuchi Chemical Industry Company, Ltd. Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd ３，５−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS6112660A (ja) * 1984-06-27 1986-01-21 Kanegafuchi Chem Ind Co Ltd 新規２−ピロリドン誘導体及び抗炎症剤
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS6412660A (en) * 1987-07-07 1989-01-17 Canon Kk Original reader
JP3611676B2 (ja) * 1996-06-24 2005-01-19 アサマ化成株式会社 パン生地の改良剤およびパンの製造方法

Also Published As

Publication number Publication date
HUT45493A (en) 1988-07-28
NZ216092A (en) 1988-08-30
AU5676686A (en) 1986-11-13
DE3681076D1 (de) 1991-10-02
DK213286D0 (da) 1986-05-07
PH23189A (en) 1989-05-29
CN86103227A (zh) 1987-01-21
JPH066571B2 (ja) 1994-01-26
FI84172B (fi) 1991-07-15
MX162717A (es) 1991-02-18
ATE66673T1 (de) 1991-09-15
ZA863352B (en) 1986-12-30
US4833160A (en) 1989-05-23
DK213286A (da) 1986-11-10
CN1014058B (zh) 1991-09-25
EP0204964B1 (en) 1991-08-28
PT82540B (pt) 1988-08-17
FI84172C (fi) 1991-10-25
NO861820L (no) 1986-11-10
FI861698A0 (fi) 1986-04-22
HU199117B (en) 1990-01-29
CA1264762A (en) 1990-01-23
PT82540A (en) 1986-06-01
JPS61257967A (ja) 1986-11-15
HU196749B (en) 1989-01-30
AU581078B2 (en) 1989-02-09
ES554775A0 (es) 1987-11-01
KR860008973A (ko) 1986-12-19
KR910004789B1 (ko) 1991-07-13
EP0204964A1 (en) 1986-12-17
HUT43040A (en) 1987-09-28
PH23225A (en) 1989-06-06
FI861698A (fi) 1986-11-10

Similar Documents

Publication Publication Date Title
ES8800148A1 (es) Un procedimiento para la preparacion de un derivado de 2-pirrolidona
DE3164764D1 (en) 1,1,2-triphenyl-but-1-ene derivatives, process for their manufacture and their use as pharmaceutical agents
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
IL87908A (en) Azaspirane derivatives and immunomodulating pharmaceutical compositions containing same
IL111454A0 (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
MY125749A (en) Aralkyl and aralkylidene heterocyclic lactams and imides
EP0614913A3 (en) Dynorphin derivatives.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
GR3005779T3 (es)
AU631025B2 (en) N-substituted derivatives of 3r, 4r-ethyl-((1-methyl-1h -imidazol-5-yl)methyl)-2-pyrrolidinone
NZ210914A (en) 4,6,6a,7,8,12b-hexahydroindolo(4,3-ab)phenanthridine,derivatives thereof and pharmaceutical compositions
FR2498184B1 (es)
GEP20001939B (en) Alkyl Derivatives of Trazodone with CNS Activity
DE2862361D1 (en) 3,4-methano pyrrolidine derivatives, compositions thereof and use as plant-growth regulating agents
MXPA98005355A (es) Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
LTIP586A (en) N-substituted heterocyclic derivatives, process fof their preparation, intermediates, process for their preparation and pharmaceutical composition
ES2000678A6 (es) Procedimiento para la obtencion de embonatos de los acidos quinolon-carboxilicos y sus derivados
ES8103082A1 (es) Procedimiento de preparacion de nuevos derivados pirido (3,4-e)-as-triazinos acilados y de sus sales de acicion aci-da de los mismos
GR3002206T3 (en) 4-oxo-1,3-benzodioxane derivative
UA29449C2 (uk) N-заміщені похідні 3-азабіцикло[3.2.0]гептану
EP0294295A3 (en) 1-arylsulfonyl 2-oxo 5-alkoxy pyrrolidine derivatives, process for their preparation, compositions containing them and their uses as medicines

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506